The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
what are some other biomarkers that you find helpful as far as understanding even more diffusely endothelial dysfunction or other markers of oxidized states that can give us more of an indication and say look you might have two people with the same degree of dis lipedema but one has a greater burden of oxidation going on than the other which would be presumably worse presumably yes
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.